The co-factor Vestigial-like 2 (Vgl-2), in association with the Scalloped/Tef/Tead transcription factors, has been identified as a component of the myogenic program in the C2C12 cell line. In order to understand Vgl-2 function in embryonic muscle formation, we analysed Vgl-2 expression and regulation during chick embryonic development. Vgl-2 expression was associated with all known sites of skeletal muscle formation, including those in the head, trunk and limb. Vgl-2 was expressed after the myogenic factor MyoD, regardless of the site of myogenesis. Analysis of Vgl-2 regulation by Notch signalling showed that Vgl-2 expression was down-regulated by Delta1-activated Notch, similarly to the muscle differentiation genes MyoD, Myogenin, Desmin, and Mef2c, while the expression of the muscle progenitor markers such as Myf5, Six1 and FgfR4 was not modified. Moreover, we established that the Myogenic Regulatory Factors (MRFs) associated with skeletal muscle differentiation (MyoD, Myogenin and Mrf4) were sufficient to activate Vgl-2 expression, while Myf5 was not able to do so. The Vgl-2 endogenous expression, the similar regulation of Vgl-2 and that of MyoD and Myogenin by Notch signalling, and the positive regulation of Vgl-2 by these MRFs suggest that Vgl-2 acts downstream of MyoD activation and is associated with the differentiation step in embryonic skeletal myogenesis.
Introduction
During development, head, trunk and limb muscle progenitors are specified by different genetic programs (reviewed in Grifone and Kelly, 2007; Mootoosamy and Dietrich, 2002; Duprez, 2002) . Once specified, myogenic cells use a common differentiation program at various places in the body. Transcriptional control of skeletal muscle gene expression is dependent on four basic-helix-loop-helix transcription factors: Myf5, MyoD, MRF4 and Myogenin, which are named the Myogenic Regulatory Factors (MRFs) (reviewed in Berkes and Tapscott, 2005) . MRFs have the ability to trigger skeletal muscle differentiation in non-muscle cells in vitro (Weintraub et al., 1991) and in vivo (Delfini and Duprez, 2004) . of skeletal muscle fibres into distinct phenotypes (slow and fast) involves transcriptional activation of transcription factor, cytoskeletal, calcium handling, metabolic and contractile proteins (Zierath and Hawley, 2004) .
Searching for genes regulating vertebrate embryonic skeletal muscle identity, we investigated the vertebrate equivalents of the Drosophila Vestigial gene. In Drosophila, Vestigial is involved in the specification and subsequent differentiation of embryonic somatic muscles and one type of adult muscles, the indirect flight muscles (Sudarsan et al., 2001; Bernard et al., 2003 Bernard et al., , 2006 Bernard et al., , 2009 Deng et al., 2009) . Drosophila Vestigial and the Vertebrate equivalent Vestigial-like (Vgl) genes code for co-transcription factors that do not contain any DNA binding sequence (Vaudin et al., 1999; Halder and Carroll, 2001; Maeda et al., 2002; Gunther et al., 2004) . They are characterised by a Vestigial domain, which interacts with members of the Scalloped/Tef/Tead transcription factor family. Tead family members control the transcription of musclespecific genes through binding to MCAT elements, in cardiac, smooth and skeletal muscle lineage (reviewed in Yoshida, 2008) . TeaD family members share a highly-conserved DNA binding domain called the Tea domain and comprise four members described in human and mice, including Tead1,2,3 and 4 (reviewed in Yoshida, 2008) . Tead1,3 and 4 members have been described as widely expressed in multiple adult tissues, while Tead2 is selectively expressed in embryonic tissues (reviewed in Yoshida, 2008) . Given the ubiquitous expression of the Tead genes, it is generally assumed that the specificity of action of these Tead family members results from the specific expression of their cofactors.
The human and mouse Vestigial-like 2 (Vgl-2) genes were identified following screens for orthologues of Drosophila Vestigial and for genes specifically expressed in skeletal muscles (Mielcarek et al., 2002; Maeda et al., 2002) . Two zebrafish Vgl-2 orthologues have also been identified as being expressed in terminally differentiated muscle fibres (Mann et al., 2007) . Three other genes belonging to the Vestigial-like family have been identified in Human: Vgl-1 and Vgl-3, which are mainly expressed in placenta (Maeda et al., 2002) , and Vgl-4, which has been described as being specific to cardiac muscles (Chen et al., 2004a) . Recently, the mouse Vgl-3 gene has been isolated and associated with the myogenic lineage during early mouse embryonic development (Mielcarek et al., 2009) .
In vitro studies have shown that Vgl-2 transcripts are upregulated following muscle differentiation in C2C12 cells (Maeda et al., 2002; Mielcarek et al., 2002) . Although Vgl-2 alone is not sufficient to initiate myogenic differentiation in fibroblast cell lines, Vgl-2 enhances the MyoD-mediated myogenic conversion of 10T1/2 (Maeda et al., 2002; Gunther et al., 2004) . Conversely, down-regulation of Vgl-2 expression using siRNA or morpholino in C2C12 cells prevents muscle cells from forming myotubes (Gunther et al., 2004; Chen et al., 2004b) . These experiments suggest a role for Vgl-2 in promoting MyoD-induced myogenesis. Mutant mice for Vgl-2 have not been produced to date. However, Vgl-2 expression has been observed in myotomes and limb muscles of mouse embryos and in adult skeletal muscle tissues (Maeda et al., 2002; Mielcarek et al., 2002) . The Vgl-2 expression and regulation in chick embryos is not known.
In the present study, we have identified and isolated chick Vgl-2 mRNA and analysed its expression during embryonic chick development. Comparing Vgl-2 expression with that of known muscle markers allowed us to establish that Vgl-2 was expressed after MyoD in all sites of skeletal muscle formation, head, trunk and limb. We also analysed the regulation of Vgl-2 expression by the Notch/Delta pathway and by the four MRFs (Myf5, MyoD, Myogenin and Mrf4). Our results suggest that in the chick embryo, Vgl-2 is associated with skeletal muscle differentiation after the MyoD step.
Results

Identification of chicken Vestigial-like 2 cDNA
Chicken Vgl-2 cDNA was isolated by RT-PCR using mRNAs extracted from chick embryos of various stages. Sequence analyses revealed that chicken Vgl-2 protein is coded by 4 exons and is constituted of 303 amino acids with a predicted molecular mass of 32 kDa (data not shown). The comparison of the deduced amino acid sequences of Vgl-2 proteins between different species showed that cVgl-2 is more homologous with human Vgl-2 (67%) than with mouse Vgl-2 (63%). In zebrafish, two Vgl-2 genes, Vgl-2a and Vgl-2b have been identified; Vgl-2a has been shown to be more similar to mammalian Vgl-2 than Vgl-2b (Mann et al., 2007) . Chick Vgl-2 protein is more similar to Vgl-2a than to Vgl-2b zebrafish proteins (58% versus 34%). The region homologous to the Drosophila SID (Scalloped Interaction Domain) of the different species is the most conserved region between Vgl-2 proteins. The SID of cVgl-2 is, respectively, 79% and 73% identical to the SID of human Vgl-2 and mouse Vgl-2 (data not shown).
2.2.
Vgl-2 expression is associated with skeletal muscle formation in chick embryos
We analysed Vgl-2 expression in the different sites of skeletal myogenesis (head, trunk and limb) during chick development by in situ hybridisation. In order to correlate Vgl-2 expression with the different steps of myogenesis, we systematically compared Vgl-2 expression with that of MyoD, whose expression reflects the commitment of myoblasts into the muscle differentiation program (Amthor et al., 1998; Delfini et al., 2000; Hirsinger et al., 2001; Bergstrom et al., 2002) .
Head myogenesis
In chick embryos, Vgl-2 transcripts were first detected at 12-somite stage in anterior regions in the future branchial arches (shown for 15-somite stage, Fig. 1A and B, arrows). Transverse sections of 17-somite stage embryos at the future branchial arch level showed that Vgl-2 expression was restricted to the surface ectoderm and to the pharyngeal endoderm (Fig. 1C) . No Vgl-2 expression was observed in the mesenchymal cells of the future branchial arches until HH22 ( Fig. 1C and D) , while at stage HH26, Vgl-2 transcripts were now detected in the myogenic core of the first branchial arch (Fig. 1E, arrow) . In order to define Vgl-2 expression in head muscles, we compared its expression with that of MyoD on adjacent sections. In the first branchial arch, at HH21, Vgl-2 expression was not observed in the myogenic core, while Fig. 1 -Chick Vgl-2 expression is associated with branchiomeric and extraocular muscles. In situ hybridisation to wholemount chick embryos at 15-somite stages (A and B), HH22 (D), HH26 (E) using the chick Vgl-2 probes. (A, B and E) The arrows indicate the future branchial arch region (A and B) and Vgl-2 expression in the central region of the first branchial arch (E). (B) is a lateral view at higher magnification of the embryo shown in (A). (C) Transverse sections at cranial level of 17-somite stage chick embryo hybridised with Vgl-2 probe showed that Vgl-2 is expressed both in ectoderm and pharyngeal endoderm. Adjacent transverse sections of HH21 (F-I) and HH24 (J-O) chick embryos at the cranial level were hybridised with Vgl-2 (F, H, J, L, N and O) and MyoD (G, I, K and M) probes. (F and G) and (J and K) are sections at the first branchial arch level, while (H and I) and (L and M) correspond to sections at the eye level. (F-I) At HH21, Vgl-2 is expressed in the surface ectoderm and pharyngeal endoderm (F, arrowheads) and in one extraocular muscle (H, black arrows), while MyoD is expressed in the myogenic core of the first branchial arch (G, white arrow) and in extraocular muscles (I, black and white arrows). (H and I) The white arrows point to future eye muscles expressing MyoD and no Vgl-2. (J-M) At HH24, Vgl-2 and MyoD expression are similarly observed in the myogenic core of the first branchial arch (J and K, arrows) as in extraocular muscles (L and M, arrows) . Vgl-2 is also expressed in the ventral region of the diencephalon (N and O). (O) is a higher magnification of the section shown in (N). aa, aortic arch; BA1, first branchial arch; BA2, second branchial arch; BA3, third branchial arch; di, diencephalon; e, eye; ecto, surface ectoderm, endo, pharyngeal endoderm; mes, mesencephalon; NT, neural tube; No, notochord; ph, pharynx.
MyoD was already expressed in this region ( Fig. 1F and G, white arrows). At this stage, Vgl-2 was expressed in one eye muscle, the lateral rectus (Fig. 1H , black arrows), but not in the ventral oblique (Fig. 1H , white arrows), while MyoD transcripts were already observed in both extraocular muscles (Fig. 1I , black and white arrows). The lateral rectus has been described as the first extraocular muscle, expressing the slow myosin indicating that this muscle differentiates first (Noden et al., 1999) . One day later, at HH24, Vgl-2 expression was detected in the mesodermal core of the first branchial arch, in a domain similar to that of MyoD (Fig. 1J and K, arrows) . At HH24, Vgl-2 was also expressed in all extraocular muscles like MyoD, although with a slightly smaller expression domain ( Fig. 1L and M, arrows and data not shown). In addition, we also detected Vgl-2 expression in neural tissues, in a restricted ventral region of the diencephalon (Fig. 1N and O) . This region will give rise to the ventromedial hypothalamus, which is involved in feeding, fear, thermoregulation and sexual activity. Interestingly, Vgl-2 has been identified as part of the transcriptome of the neonatal ventromedial hypothalamus in mice (Kurrasch et al., 2007) . Our data indicate that Vgl-2 is a precocious marker of the presumptive hypothalamic regions in chick embryos.
In conclusion, Vgl-2 expression was observed in differentiating branchiomeric and extraocular muscles in a domain similar to that of MyoD, but one day later.
Axial myogenesis
At the 15-somite stage, MyoD transcripts were observed in the most anterior somites ( Fig. 2A, arrow) , while no Vgl-2 expression was observed in somites at this stage (Fig. 1A) . At the 20-somite stage, Vgl-2 expression could be observed in the medial parts of the first anterior somites (Fig. 2B , arrow), while MyoD expression was observed in all somites (data not shown, Hirsinger et al., 2001) . Vgl-2 transcripts were not observed in the heart (Fig. 2B) . As development proceeded, Vgl-2 expression in somites progressed towards the most caudal somites (Fig. 2C) and Vgl-2 expression domain appeared restricted compared to that of MyoD ( Fig. 2D and D 0 , arrowheads). We next compared Vgl-2 expression with that of other muscle markers during axial myogenesis. New epithelial somites undergo epithelial to mesenchymal transition to form sclerotome and dermomyotome. The dermomyotome will then develop into myotome and dermis (Christ and Ordahl, 1995) . At HH20, in caudal somites, Vgl-2 transcripts were restricted to the central myotome (Fig. 2E , black arrow), while MyoD was expressed throughout the myotome (Fig. 2F , black and white arrows). Vgl-2 was not expressed in dermomyotome (Fig. 2E, arrowheads) , which was labelled with Pax3 and FgfR4 expression ( Fig. 2G and H, arrowheads). It should be noted that at this stage and axial level, Pax3 and FgfR4 displayed an additional expression in myotomes (Fig. 2G and H, arrows) , consistent with the maintenance of Pax3 and FgfR4 expression during the dissociation of the muscle progenitors located in the central dermomyotome to populate the myotome (Ben-Yair and Kalcheim, 2005; Gros et al., 2005; Marcelle et al., 1995) . At more rostral levels, in the interlimb region, Vgl-2 transcripts were still only observed in the central myotomes and not in dermomyotomes, nor in the epaxial and hypaxial lips ( Fig. 2I and J) . In addition, Vgl-2 was not expressed in the anterior and posterior regions of the myotomes (Fig. 2K , white arrow), which are known to be positive for FgfR4 expression at this stage and axial level (Fig. 2L , white arrow; Kahane et al., 2001) . At HH23, Vgl-2 expression was still observed in the central regions of axial muscles labelled by MyoD expression (Fig. 2M and N, black arrows) and was not observed in the epaxial myotomes, while MyoD transcripts were clearly detected in this region ( Fig. 2M and N, white arrows). Vgl-2 expression was not observed in the remaining epaxial and hypaxial lips labelled by Pax3 and FgfR4 ( Fig. 2O and P, arrowheads).
In conclusion, during chick axial myogenesis, Vgl-2 was expressed after MyoD and its expression was restricted to the central part of myotomes.
Limb myogenesis
Limb myogenic cells originate from the brachial and lumbar somites (somites 16-21 for the wing, somites 26-31 for the leg) (Chevallier et al., 1977; Christ et al., 1977; Zhi et al., 1996) . These migrating muscle progenitors expressed the Pax3 and FgfR4 genes (Marcelle et al., 1995) . Vgl-2 transcripts were not observed in the migrating muscle progenitors, labelled by Pax3 and FgfR4 expression at HH20 (Fig. 3A -D, arrows). In chick forelimbs, MyoD expression was first observed at HH22, in a restricted domain, compared to that of Pax3 and Myf5 (Delfini et al., 2000) . Vgl-2 expression was first detected at HH24 in the dorsal and ventral muscle masses of the forelimb, with a restricted expression domain compared to that of MyoD ( muscle differentiation occurs at HH26 (Duprez, 2002) . Terminal differentiation will give rise to the formation of plurinucleated skeletal muscle fibres, which are visualised by the expression of myosin heavy chains. From HH28, the dorsal and ventral muscle masses progressively split to form the individual limb muscles (Tozer et al., 2007) . At HH32, when all limb muscles were clearly individualised, Vgl-2 expression did not display any restriction of expression to one or several specific muscles and was observed in all limb muscles as were MyoD and FgfR4 expression ( (E-L) At HH20, at caudal level, Vgl-2 transcripts are observed in the central region of the myotome (E, black arrow) labelled with MyoD expression (F, black arrow), but not in the epaxial and hypaxial regions of the myotome in which MyoD expression is observed (E and F, white arrows). Vgl-2 transcripts are not detected in the dermomyotome expressing Pax3 and FgfR4 (G and H), nor in epaxial or hypaxial lips (E-H, arrowheads). (I and J) At HH20, in interlimb somites, Vgl-2 is expressed in the central region of the myotome similarly to MyoD (I and J, black arrow). Vgl-2 expression does not extend to the epaxial and hypaxial regions of the myotome, in contrast to MyoD (I and J, white arrows). Vgl-2 transcripts are not observed in the dermomyotome and its epaxial and hypaxial lips (I and J, arrowheads). (K and L) In anterior or posterior regions of interlimb somite, delineated by FgfR4 expression, Vgl-2 is not expressed, (K and L, white arrow). (M-P) At HH23, at the interlimb level, Vgl-2 transcripts are present in the myotome labelled by MyoD (M and N, black arrows), but not in its more epaxial part, in contrast to MyoD (M and N, white arrows). Vgl-2 is not expressed in the remaining epaxial and hypaxial lips of the dermomyotome labelled by Pax3 and FgfR4 (M-P, arrowheads). dm, dermomyotome; e, eye; fl, forelimb; h, heart; hl, hindlimb; my, myotome; NT, Neural Tube; scl, sclerotome.
transcripts were never observed in MF20-positive fibres ( In conclusion, during limb myogenesis, Vgl-2 was expressed after MyoD in limb muscle masses and then in all individualised muscles. Altogether, the expression data allowed us to conclude that during craniofacial, axial and limb myogenesis, Vgl-2 was expressed in a similar domain to that of MyoD, but after MyoD activation.
2.3.
Vgl-2 expression is regulated by Notch signalling similarly to MyoD and Myogenin Notch signalling has been shown to regulate muscle formation in vertebrate embryos and in cultured cell lines (Delfini et al., 2000; Hirsinger et al., 2001; Schuster-Gossler et al., 2007; Vasyutina et al., 2007) . Moreover, the nuclear mediator of Notch signals, the transcription factor RBP-J, is essential to the maintenance of muscle progenitor cells and the generation of satellite cells (Vasyutina et al., 2007) . In chick embryonic limbs and somites, Delta1-activated-Notch led to a down-regulation of MyoD expression, while the expression of Pax3 and Myf5 was not affected, leading to impaired differentiated limb and axial muscles (Delfini et al., 2000; Hirsinger et al., 2001) . In order to determine whether Vgl-2 expression was affected by Notch signalling, we analysed Vgl-2 expression after Delta1 overexpression in chick limbs. RCAS-Delta1 expressing cells were grafted into the lateral plates of HH17 embryos at limb level (Fig. 5A) . Seventy-two hours later, Delta1 expression revealed the extent of the virus spread (Fig. 5F ). In these conditions, Vgl-2 expression was down-regulated like that of MyoD in the dorsal and ventral muscle masses of the Delta1-infected wing, compared to the normal Vgl-2 and MyoD expression domains (Fig. 5B, C , G and H, arrows) . In contrast, the expression of FgfR4 and Six1 genes, which labelled muscle progenitors, was not affected by Delta1 misexpression (Fig. 5D , E, I and J). Moreover, analysis of the expression of other genes involved in terminal muscle differentiation showed a clear down-regulation of Desmin, Mef2c and Myogenin expression following exposure to Delta1-activated-Notch (Fig. 5K-V) . These results showed that Vgl-2 expression was down-regulated upon Notch activation in chick limbs. Moreover, Vgl-2 regulation by Notch signalling was similar to that of all the differentiation genes we tested.
2.4.
Regulation of Vgl-2 expression by the MRFs in the neural tube context Vgl-2 endogenous expression and its regulation by Notch suggested a role for Vgl-2 after the initiation of skeletal muscle differentiation. We have previously shown that ectopic MyoD or Myf5 is able to induce skeletal muscle differentiation in the chick neural tube (Delfini and Duprez, 2004) . This pro- vides us with an in vivo system, in which to study gene regulation between muscle factors. We took advantage of this system to determine whether Vgl-2 expression was regulated by the MRFs. Twenty-four hours after electroporation, the ectopic expression of the electroporated gene was detected in the right sides of the neural tube and in migrating neural crest cells (Fig. 6A, E, I and O, arrows). Forced expression of mMyf5 did not activate Vgl-2 expression, 24 h after electroporation, while MyoD expression was induced (Fig. 6A-D , Table 1 ). The forced expression of the other three MRFs, mMyoD, mMyogenin and mMrf4 activated the ectopic expression of Vgl-2 in the neural tube as well as that of MyoD (Fig. 6E-T , Table 1 ). The expression of Myogenin was activated after the ectopic application of mMyf5 ( (Fig. 6Q , Table 1 ). The activation of MyoD expression but not that of Myogenin following mouse Mrf4 electroporation (Fig. 6O-Q ) differs with the activation of Myogenin expression but not that of MyoD following chick Mrf4 electroporation (Sweetman et al., 2008) . The reasons for this difference were not clear although an obvious explanation would be a functional difference between chick and mouse Mrf4. Myf5 expression was never induced after ectopic activation of any of the four MRFs (Table 1 , Delfini and Duprez, 2004; Sweetman et al., 2008) . The fact that Vgl-2 expression can be activated in the absence of chick Myf5 (following mMyoD, mMyogenin and mMrf4 electroporation) combined with the absence of Vgl-2 activation following mMyf5 electroporation indicates that mMyf5 does not regulate Vgl-2 expression. These experiments showed that each of the MRFs, MyoD, Myogenin or Mrf4 was sufficient for Vgl2 expression and indicated that Vgl-2 was a direct or indirect target of these MRFs in the neural tube context. Fig. 6 -mMyoD, mMyogenin or mMrf4 is sufficient for Vgl-2 expression in the neural tube. Chick embryos were electroporated with pCAb-mMyf5 (A-D), pCAb-mMyoD (E-H), pCAb-mMyogenin (I-N) or pCAb-mMRF4 (O-T) in the neural tube at HH13. Adjacent transverse sections of each electroporated embryos, 24 h after electroporation, were hybridised with the ectopic genes mMyf5 (A), mMyoD (E), mMyogenin (I) and mMrf4 (O). The corresponding adjacent transverse sections were hybridised with the putative target genes, Vgl2 (C, D, G, H, L-N and R-T), MyoD (B, F, J and P), Myogenin (K and Q). For the Vgl-2 gene, immunohistochemistry using the antibody against GFP were performed after in situ hybridisation against Vgl-2 probe following mMyf5 (C and D), mMyoD (G and H), mMyogenin (L-N) and mMrf4 (R-T) electroporation. D is the merged picture of GFP expression (not shown) and C (Vgl-2 transcripts). H is the merged picture of GFP expression (not shown) and G (Vgl-2 transcripts). N is the merged picture of L (GFP) and M (Vgl-2 transcripts). T is the merged picture of R (GFP) and S (Vgl-2 transcripts). Arrows point to the right parts of the electroporated neural tubes. Arrowheads point to the endogenous gene expression. (A-D) Following mMyf5 electroporation, Vgl-2 expression was not ectopically induced in the right side of the neural tube. Vgl-2 and MyoD expression was ectopically induced in the right sides of the neural tube following mMyoD (E-H), mMyogenin (I-N) and mMrf4 electroporation (O-T). Myogenin expression was induced after mMyogenin electroporation (K) but not induced after mMrf4 electroporation (Q). No, notochord; NT neural tube.
MRF electroporation in limb somites blocked the migration of the electroporated cells
In order to analyse Vgl-2 regulation in a muscle context, we overexpressed the MRFs in limb muscle precursor cells in somites. Limb myogenic cells of forelimbs originate from the hypaxial dermomyotomes of the 16th to 21st somites (Chevallier et al., 1977; Christ et al., 1977) . As control experiment, we first electroporated the lateral parts of the brachial somites at HH15 with a construct encoding GFP. Twenty-four 
+, activation of ectopic expression; À, no detectable; n.d., not determined.
hours later, GFP fluorescence could be visualised in ovo in the electroporated somites and in limbs (Fig. 7A ). This type of experiment did not affect the migration of somitic cells to the limb buds, assayed by the presence of GFP-positive cells in limb buds, visualised by GFP fluorescence in ovo, GFP transcripts and protein ( Fig. 7A-F) . The migration of muscle progenitors assayed by Pax3 expression was found to be normal ( Fig. 7G-I) . Moreover, GFP expression matched with that of Pax3 in migrating cells, indicating that we mainly targeted limb muscle precursor cells (Fig. 7G-I ). However, we could occasionally detect GFP-positive cells (transcripts or protein) that were Pax3-negative in distal limb regions, indicating that endothelial cells could also be electroporated with this technique. Since endothelial cells have been shown to migrate before the myogenic precursors (Tozer et al., 2007) , we believe that we mainly targeted muscle precursor cells with this technique. Similar limb somite electroporation with each MRF construct prevented the migration of the electroporated muscle precursors into the limb (Fig. 8) . In the presence of any ectopic MRF, GFP fluorescence was restricted to somites (shown for mMyoD electroporation in Fig. 8A ) in contrast to the presence of GFP-positive cells migrating into the limbs following GFPonly electroporation (Fig. 7A-F) . Twenty-four hours after electroporation, mMyoD-, mMyf5-, mMyogenin-and mMrf4-expressing cells were still located in the hypaxial regions of the electroporated somites (Fig. 8B, D, G and H) . The non-electroporated cells migrated normally into the limbs, since Pax3 displayed a normal limb expression (Fig. 8C, shown for  mMyoD electroporation) . The expression domain of the ectopic gene visualised by in situ hybridisation (purple) matched with the GFP protein (Fig. 8D-F, shown for mMyf5 electroporation) . However, high magnifications showed that although many cells were double labelled, we observed mMyf5-expressing cells, which did not display GFP fluorescence (Fig. 8D 0 -F 0 , arrows). This was also observed in control conditions after GFP-only electroporation (Fig. 7D-F, arrows) . This is probably due to the quenching of the fluorescence by the blue precipitate used to reveal the probe of interest. This observation implies that GFP is a good indication of the global location of the ectopic gene but precludes any analysis at a cellular level.
In conclusion, precocious expression of any MRF in limb muscle precursor cells of the hypaxial lip prevented their migration into limb buds.
2.6.
Regulation of Vgl-2 expression by the MRFs in the somite context Electroporation of MRFs in limb somites led to an accumulation of the ectopic MRF in the hypaxial regions of dermomyotomes, which allowed us to study the consequences for muscle gene expression. Similar to the neural tube situation, mMyf5 did not activate Vgl-2 expression in somites, 24 h after electroporation, while MyoD and Myogenin expression was activated (Fig. 9A-D 0 , arrows). Ectopic mMyoD in limb somites activated the expression of Vgl-2 and that of MyoD, compared to the endogenous Vgl-2 and MyoD expression in the nonelectoporated somites, which served as an internal control ( Fig. 9E -G 00 ). FgfR4 expression was also induced by mMyoD (data not shown) in lateral somites, as in the neural tube context (Delfini and Duprez, 2004) . Ectopic mMyogenin in lateral somites also activated the expression of Vgl-2, MyoD and Myogenin compared to the endogenous expression in the non-electoporated somites (Fig. 9H-K  0 ) . The expression domains of etopic mMrf4 were always totally included into the endogenous expression domains of Vgl2 and MyoD, preventing us to determine whether Vgl-2 expression was activated or not.
In conclusion, consistent with the neural tube electroporation, either mMyoD or mMyogenin activated Vgl-2 expression in a muscle context.
Discussion
3.1.
Vgl-2 expression is associated with all the sites of skeletal muscle differentiation in chick embryos
We have established that Vgl-2 is expressed at all sites of myogenesis -head, trunk and limb -in chick embryos. The expression in chick somites and limb muscle masses is consistent with Vgl-2 expression in mouse embryos (Maeda et al., 2002; Mielcarek et al., 2002) . We have shown that Vgl-2 is expressed after MyoD at all sites of chick myogenesis. In mouse somites, Vgl-2 transcripts have been observed significantly earlier than those of MyoD (Mielcarek et al., 2002) . However, mouse Vgl-2 expression is clearly associated with that of the muscle differentiation gene Myogenin in mouse somites and limbs (Maeda et al., 2002; Mielcarek et al., 2002) . The Vgl-2 expression in branchiomeric and extraocular muscles has not been previously described in mouse embryos. In addition to the specific genetic programs underlying the specification of different groups of muscles (head, trunk and limbs), there is also genetic heterogeneity among head muscles during development (Bothe et al., 2007; Grifone and Kelly, 2007) . Despite this heterogeneity, Vgl-2 is expressed in all chick head muscles. The general Vgl-2 location in trunk, limb and head embryonic muscles suggests a function for Vgl-2 downstream of the specification step, such as a general function associated with skeletal muscle differentiation.
The expression data does not argue for a Vgl-2 role in the formation of a specific muscle type, at least in chick embryos. This differs from the situation in Drosophila, where Vestigial regulates a specific developmental program responsible for one type of adult muscle development (Sudarsan et al., 2001) . However, an additional and more general role in promoting muscle differentiation has been also highlighted for Vestigial (Bernard et al., 2003 (Bernard et al., , 2006 (Bernard et al., , 2009 Deng et al., 2009) , indicating that one Vestigial function might be conserved across evolution. A differential accumulation of Vgl-2 transcripts has been described between slow and fast adult mouse muscles (Mielcarek et al., 2002) . Moreover, an important role for Tead transcription factors (Vgl partners) in directing slow-muscle-specific gene expression and in potentiating type I myosin heavy chain induction in response to mechanical overload has been highlighted (Karasseva et al., 2003) . In embryonic chick wings, isoforms of slow myosin heavy chains display a regionalised expression in muscle masses as early as HH27, and at HH32 individual muscles display a characteristic distribution of slow myosin heavy chains (Robson et al., 1994; Duprez et al., 1999) . We did not observe any restricted Vgl-2 expression in individualised muscles until HH38 (data not shown), indicating an absence of correlation between Vgl-2 transcripts and chick skeletal muscle fibre types. However, we cannot exclude a Vgl-2 transcript restriction in fibre types at later stages or a restriction at a protein level.
3.2.
Vgl-2 expression is regulated as that of muscle differentiation genes by Notch signalling It has been previously shown that alteration of Notch signalling in chick and mouse models interferes with MyoD without modifying Myf5 gene expression, indicating that MyoD expression is regulated by Notch signalling, while that of Myf5 is not (Delfini et al., 2000; Hirsinger et al., 2001; Vasyutina et al., 2007) . The ectopic activation of Notch in chick also interferes with muscle differentiation, as assayed by the diminution of MyoD and myosin expression (Delfini et al., 2000; Hirsinger et al., 2001) . We now provide evidence that the expression of other known muscle differentiation genesMyogenin, Desmin and Mef2C -is also regulated by Notch signalling, while the expression of other muscle progenitor markers, such as FgfR4 and Six1 is independent of Notch pathway. Vgl-2 down-regulation after Notch activation suggests that this gene is associated with skeletal muscle differentiation. However, mVgl-2 expression is not affected in the absence of Notch signalling in early mouse embryos (Mielcarek et al., 2009) . In contrast, in Drosophila it has been shown that activation of the Notch pathway leads to a down-regulation of Vestigial expression, while repression of the Notch pathway induces an ectopic activation of Vestigial expression (Bernard et al., 2009 ). Moreover, the promoting effect of Vestigial on indirect flight muscle differentiation requires an inhi-bition of the Notch signalling pathway (Bernard et al., 2006 (Bernard et al., , 2009 . These Drosophila data are fully consistent with our view that when muscle differentiation is impaired, Vgl-2 expression is altered.
3.3.
Vgl-2 expression is differentially regulated by the MRFs
We have shown that among the four MRFs, mMyoD, mMyogenin or mMrf4 activates the expression of Vgl-2 in muscle or neural tube contexts, while mMyf5 is not able to do so. Although each MRF is capable to activate the skeletal muscle differentiation program and to compensate for each other, their functions during embryogenesis are distinct. Mouse mutant analyses clearly showed that MyoD, Myogenin and Mrf4 functions are associated with the muscle differentiation step (Hasty et al., 1993 : Nabeshima et al., 1993 Rawls et al., 1998) , while Myf5 is involved in muscle specification (Tajbakhsh et al., 1997) . Moreover, Myf5 does not support muscle differentiation in the absence of the other three MRFs (Valdez et al., 2000) . The absence of Vgl-2 regulation by the Myf5 gene is consistent with the differential regulation of Myf5 and Vgl-2 expression by Notch signalling in chick limbs and with Vgl-2 endogenous expression. It has to be noted that chick and mouse Myf5 are both able to activate ectopic MyoD and Myogenin expression in the neural tube, 24 h after electroporation (Delfini and Duprez, 2004; Sweetman et al., 2008) . We hypothesised that in this context, mMyf5 activate (an) additional factor(s), which prevent(s) Vgl-2 activation despite the presence of MyoD and Myogenin. Either MyoD and Myogenin, which are associated with muscle differentiation is sufficient for Vgl-2 expression in a muscle context, but also in an ectopic context, the neural tube. Since MyoD and Myogenin activate mutually their expression this is difficult to assess which one (or both) activate Vgl-2 expression. The Vgl-2 activation in the absence of Myogenin expression (following mMrf4 electroporation in the neural tube), indirectly suggests that MyoD would be responsible of Vgl-2 activation. Although the absence of MyoD is compensated by Myf5 and/or MRF4, MyoD mutant mice display a delay of 2.5 days of limb muscle differentiation (Kablar et al., 1997; Kassar-Duchossoy et al., 2004) . Moreover, MyoD expression has been linked to withdrawal from the cell cycle in the muscle context (Crescenzi et al., 1990; Sorrentino et al., 1990; Trouche et al., 1993; Kitzmann et al., 1998; YablonkaReuveni et al., 1999) . The fact that MyoD is sufficient for Vgl-2 expression, combined with the fact that Vgl-2 is expressed after and in a similar domain compared to that of MyoD indicates that Vgl-2 is acting downstream of MyoD activation. Interestingly, it has been shown in mice that the putative partners for Vgl-2, Tead2 and Tead4, are downstream and direct targets of MyoD, suggesting that they relay the differentiation signal initiated by MyoD (Blais et al., 2005; Zhao et al., 2006) . Moreover, Tead2 and Vgl-2 transcripts have been observed to be up-regulated at a key Day 3 time point after skeletal muscle regeneration; this time point is concomitant with the stage of myoblast differentiation in this system (Zhao et al., 2006) . Lastly, functional MCAT elements (binding sites of Tead) have been identified in skeletal muscle structural genes, including skeletal a-actin and type I myosin heavy chain (reviewed in Yoshida, 2008) .
In summary, Vgl-2 expression is associated with all sites of skeletal myogenesis, is observed after that of MyoD, is positively regulated by the MRFs associated with skeletal differentiation and is negatively regulated by Notch signalling. This indicates a role for Vgl-2 in myogenesis downstream of MyoD activation and associated with the muscle differentiation step.
4.
Materials and methods
Chick embryos
Fertilized chick eggs from commercial sources, JA 57 strain (Morizeau, Dangers) or White Leghorn (HAAS Kaltenhouse) were incubated at 38°C. Before E2, embryos were staged according to somite number. After E2, chick embryos were staged according to Hamburger and Hamilton, HH (Hamburger and Hamilton, 1992) .
Molecular biology
The sequence of human Vestigial-like 2 (Vgl-2) was used in a BLAST search of chicken assembled genome to identify chicken Vgl-2 gene (International Chicken Genome Sequencing Consortium, 2004). Chicken Vgl-2 gene was identified as located on Chromosome 3. To obtain the chicken Vgl-2 cDNA, total RNA was isolated from chicken embryos of various stages and used for reverse transcription-PCR using the following pair of primers: Sense primer (5 0 GAACGCGAGTTGATG ACC3 0 ) and antisense primer (5 0 AAATTCTGACAAGTGC CACC3 0 ). The RT-PCR product (1.6 kb) was ligated into pDrive cloning vector (Qiagen) and sequenced. Chicken Vgl-2 mRNA sequence has been submitted to Genbank (Accession No.: FJ594744). The coding sequence of mouse Myogenin and mouse Mrf4 (a gift from Pascal Maire, Cochin Institute, Paris) were inserted into the pCAb vector, which allows efficient expression in chicken embryos. PCR were performed on original plasmids in order to add the EcoRI and XhoI sites on either side of the coding sequence and PCR products were ligated into the pCRII-Topo vector (Invitrogen) before the insertion into the pCAb vector.
4.3.
In situ hybridisation to wholemount embryos and to tissue sections Chick embryos were fixed and processed for in situ hybridisation to wholemounts and wax sections as previously described (Tozer et al., 2007) . For in situ hybridisation, the antisense digoxygenin labelled RNA probes were prepared as described: chick Delta1, FgfR4, Pax3, MyoD and Myogenin (Delfini et al., 2000) , mouse MyoD, mouse Myf5, chick Myogenin, Six1 and Mef2c (Delfini and Duprez, 2004) . The mouse Myogenin and Mrf4 probes were synthesised using the Sp6 polymerase after cutting by NotI the pCRII-Topo-mMgn or pCRII-Topo-mMrf4 plasmids. The GFP probe was synthesised using T7 polymerase after cutting by EcoRI a pCS2-GFP plasmid. The Desmin probe originated from the UMIST EST library (Boardman et al., 2002) . The chick Vgl-2 transcripts were detected using either a probe originating from the UMIST EST library and corresponding to the three first exons (clone 976P9, Boardman et al., 2002) or a probe corresponding to the full length mRNA isolated by RT-PCR (see above). In this latter case, the antisense Vgl-2 probe was synthesised using T7 polymerase after cutting by HindIII.
Immunohistochemistry
Differentiated muscle cells were detected on sections using the monoclonal antibody MF20 that recognizes sarcomeric myosin heavy chains (Developmental Studies Hybridoma Bank, University of Iowa). GFP protein was detected using a monoclonal antibody (Roche). Immunohistochemistry was performed after in situ hybridisation experiments.
Production and grafting of RCAS-Delta-expressing cells
Chick embryo fibroblasts were transfected by RCAS-Delta1 or RCAS alone as described by Delfini et al., 2000 . Briefly, retrovirus expressing cells were prepared one day before grafting by transferring cells from culture plates into bacterial Petri dishes. In such conditions, cells will form aggregates, which were used for grafting into the presumptive limb fields of HH15/E2.5 White Leghorn embryos. Grafted embryos were re-incubated and harvested 3 days after grafting, at HH27/E5.5. They were processed for in situ hybridisation on adjacent sections. For each embryo, left wing was used as an internal control and was compared to the grafted right wing at the same proximo-distal level. Grafts of cells expressing only RCAS do not lead to any phenotype or any modification of gene expression (data not shown). The expression of each gene was analysed in grafted and control limbs from at least four different embryos.
4.6.
Neural tube and somite electroporation
The neural tubes of HH13/E2 embryos were co-electroporated with two constructs, pCAb-eGFP and pCAb-mMRF at 0.2 lg/ll and 0.8 lg/ll, respectively. Four pCAb-mMRF constructs were used: pCAb-mMyf5 (Delfini and Duprez, 2004) , pCAb-mMyoD (Delfini and Duprez, 2004) , pCAb-mMyogenin and pCAb-mMrf4 (see the Section 4.2 for details of constructions). A solution containing DNA (not more than 1 lg/ll final), Fast Green 0.1% and sucrose 12% in water was injected into the lumen of the neural tube of HH13/E2 embryos. Commercial silver electrodes were placed at trunk level of the embryo. An Intracell electroporator (TSS20 Ovodyne) was used to deliver 4 unilateral pulses of 35 V and 50 ms each, with an interval of 500 ms between each pulse. Embryos were re-incubated and harvested 24 h after electroporation.
The hypaxial lips of dermomyotomes at wing level were electroporated according to the technique described by Scaal et al., 2004 and Bonafede et al., 2006 , with modifications, especially of the DNA concentration, the level of injected somites and the voltage. Briefly, the solution containing DNA (at a maximal final concentration of 1 lg/ll) was injected into the 16th to 21st somites of 25-somite old embryos. Selfmade electrodes handled by a commercial holder (to maintain a constant spacing of 4 mm) were positioned either sides of the embryo, at the level of dermomyotomal hypaxial lips.
The Intracell electroporator was used to deliver 5 unilateral pulses of 55 V and 20 ms each, with an interval of 200 ms between each. Embryos were re-incubated and harvested 24 h after electroporation. The efficacy of electroporation was controlled by visualising GFP fluorescence in ovo. Embryos were co-electroporated with pCAb-eGFP and pCAb-mMRFs at the same concentration as that used for neural tube electroporation (0.2 lg/ll for GFP and 0.8 lg/ll for DNA of interest).
Control embryos were electroporated with pCAb-eGFP alone at 1 lg/ll, into the neural tube and the somites. The neural tube and somite electroporation with 1 lg/ll pCAbeGFP never modified endogenous gene expression nor induced ectopic gene expression (Fig. 7 and data not shown) .
For the gene expression analyses in electroporated embryos (neural tubes and somites), the expression of each gene was analysed on at least four different electroporated embryos.
